Bond And Money Market

We present a matrix detailing some movement in some key market rates (domestic and global) and key events:

Parameters 30-July-21 30-June-21 30-July-20
RBI Repo Rate % 4.00 4.00 4.00
5Y AAA PSU % 6.20 6.18 5.90
1 year CD % 4.02 4.16 3.75
10Y Gsec % 6.20 6.05 5.84
CPI (%) 6.26 6.30 6.23
IIP (YoY) % 29.27 134.44 -33.38
US 10Y % 1.22 1.47 0.53
Dollar Rupee 74.42 74.33 74.81

Source: Bloomberg; Data as on July 30th, 2021

It was a steady month for the debt markets as all the rate indicators moved in a narrow range. The new 10-year benchmark government of India (GoI) bond was issued at a cut-off yield of 6.1%. However, through the month, the yields drifted higher as there remained little reasons for the markets to cheer. While a silver lining was the drop in the US 10-year treasury yield by around 25 basis points, a persistently high domestic inflation dampened the market sentiments. With retail inflation measured by Consumer Price Index (CPI) firmed entrenched at above the 6% limit, it may continue to remain a worrying factor for the markets. What remains to be watchful is the Goods and Services Tax (GST) collections as we move ahead as robustness in the collections may assuage the market players of the borrowing program remaining within the budgetary limits. With liquidity continuing to remain easy, money market levels remained soft through the month.

Looking Ahead
  • The MPC met in the first week of August. While all the policy rates remained unchanged, the stance on a continued accommodative policy met with a dissent from one member of the MPC. The MPC also changed the average inflation forecast for the year from 5.30 % to 5.70 % marking a large upward move in the inflation. Separately RBI also announced larger Variable Reverse Repo rate auctions through the quarter, aimed at normalizing the liquidity in the banking system. The debt markets sold off after the policy and yields moved by around 10 bps
  • We think the dissenting voices within MPC may increase with inflation remaining a concern and the RBI would first move towards normalizing the liquidity deluge in the banking system
  • We remain apprehensive of a gradual rate rise as we move through the year. We believe that the markets may stop coat tailing the RBI, and may remain apprehensive of a commodity prices rise induced inflation and a larger borrowing program
  • The possibility of a bear flattening of the yield curve exists with long term rates rising lesser than short term rates
  • We also believe that AAA credit spreads are very tight and the probability of spreads to increase in the near future remains a distinct possibility
  • Liquidity being in sustained surplus mode, the extreme short end of the yield curve may remain stable
Scheme Specific Strategies for Debt schemes
  • Mahindra Manulife Low Duration Fund
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 130 days
    • We will maintain the maturity as we move ahead through the next month
    • The YTM of the portfolio is around 3.90 %
    • With surplus liquidity conditions we expect the extreme short end money market rates to remain benign
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
  • Mahindra Manulife Dynamic Bond Yojana
    • The YTM of the portfolio has decreased to around 5.50 %.
    • The Modified Duration of the portfolio (MD) decreased to around 3.35
    • While we have decreased the duration of our portfolio, we intend now to remain steady at these levels
    • We are likely to continue with the non AAA credits carrying near term maturities in our portfolio till maturities and consider replacing them preferably with high quality debt instruments.
  • Mahindra Manulife Short Term Fund
    • The YTM of the portfolio is around 5.07%
    • The Modified duration of the portfolio increased to 1.80 years
    • Our portfolio continues to have a large allocation towards gilts as we are wary of the spreads increasing in AAA credits.
Equity Market

We present a summary of changes in key Indian & Global equity indices


S&P BSE Sensex Nifty 50 BSE Midcap BSE Small Cap Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance 0.20% 0.30% 2.40% 6.20% 3.10% 8.10% 1.30% 2.30% 1.20%
1 Yr Performance 39.80% 42.30% 67.80% 105.70% 79.80% 110.00% 32.20% 34.40% 36.60%

Source: Bloomberg Performance - Absolute returns | Data as on July 30, 2021

Indian markets continued the broad-based rally in July with the Small Cap and Mid cap indices performing better than the Nifty 50 that ended almost flat. The markets were driven by the increasing retail participation in equity markets, both directly as well as through mutual fund schemes while foreign portfolio investors (FPIs) were net sellers during the month. On the sectoral front, metals and information technology (IT) outperformed Nifty 50 while auto and energy counters underperformed Nifty 50.

Globally, the equity markets continue to remain in positive zone, with exception being China and Hong Kong. Optimism over economic recovery owning to vaccination leading to normalisation of services activity in USA and Europe boosted the sentiments. Meanwhile, US Federal Reserve’s (Fed) in its July policy meeting maintained the status quo citing current high inflation as being transitory and kept its policy guidance on rate hike in CY23 intact. Over and above the expansionary monetary policy by Fed, the fiscal support by the US government also supported the economic recovery in the post covid world. Unemployment benefits and/or pay protection plan in USA has helped majority American citizens get income support and maintain their living. The income support plan in USA is due for review and revision in September 2021 and the revised terms would be keenly monitored. Among other global indices, China and Hong Kong markets fell sharply in July 2021 as policy actions taken by Chinese government on regulating education companies as well as newly listed company Didi pulled down the tech-platform companies.

In India’s context, we would monitor RBI’s policy action as inflation remains high and any move towards tightening can hurt economic recovery prospects. This was evident in the past when monetary easing supported the mid and small cap segment in general while tightening hurt them. This is critical especially in the backdrop of a super-normal rally in mid n small caps. From the covid lows in March 2020 as well as in past 1-year, Nifty Smallcap 100 Index rallied 212% and 110%, respectively, while Nifty Midcap 100 Index ended up 153% and 80% as well. Considering the sharp rally amidst the delayed recovery due to covid, small cap and mid cap index as an aggregate appear more expensive than the large cap indices like Nifty or Nifty 100.

On Covid front while vaccination drive remains a focus, there are early reports about emergence of delta variants of covid in western world. Clearly the hopes of economic recovery and market sentiments are based on successful post-vaccination normalisation and not factoring third wave of covid.

Looking Ahead

While the monetary policy response on rate hike seems well communicated, the negative surprise can arise from tapering of the incremental liquidity by Fed. The fiscal policy support in USA (direct payment and unemployment benefits) has achieved what years of easy monetary policy by Fed could not do, create inflation. Yes, there are other factors like Chinese Yuan appreciation, supply disruption and commodity price that too contributed to inflation. But the demand generated by fiscal support has a relevant role and hence policy decision on further continuation of unemployment benefits remains to be evaluated.

The earnings season for Q1FY22 has been good till now though the base effect makes any comparison with FY21 is not very relevant. FY22 as of now is likely to be a replay of FY21 where economy normalised during Q3 festive season. Perhaps a fiscal policy support is needed to boost economy towards double digit growth.

While the power of asset allocation to equity in past 12-15 months has been seen, the power of market cycles in terms of capitalizations has crucial role to play. What started as a large cap driven recovery in passed leadership baton to mid cap and then to small caps. The economic cycle of growth and corporate earnings, navigate across market capitalization driven by policy actions on both fiscal and monetary front. We believe this re-emphasises the need to be flexible in choosing companies across market capitalizations. Yes, there are clearly Risks (Uncertainty) in Markets and its relationship with expected Returns. Large Cap, Mid Cap and Small cap as a segment, play a critical role in a portfolio construction for investors and they may always choose to manage it themselves or choose to entrust to mutual funds who have the flexible approach.

Investors with lumpsum investments style could have an asset allocation strategy (equity as a % of portfolio) to try and benefit from greed and fear phases. Alternately, the strategy could be to really stick to longer term outlook rather than focusing on 1-2 years volatility. For investors with SIP investments such phases are not so relevant as investor is still in accumulation phase for wealth creation over the 5-7 years. SIP may be a good alternate to avoid the behavioural traps during the extreme phases of markets. We maintain that investors use SIP as part of core investment philosophy and use the lumpsum route during the extreme phases to top-up on their SIPs during the fearful times amidst the volatility

Source: Bloomberg

Scheme Specific Strategies for Equity schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
  • Mahindra Manulife ELSS Kar Bachat Yojana
  • Mahindra Manulife Rural Bharat and Consumption Yojana
  • Mahindra Manulife Large Cap Pragati Yojana
  • Mahindra Manulife Top 250 Nivesh Yojana
  • Mahindra Manulife Focused Equity Yojana
Scheme Specific Strategies For Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.

    Debt:

    • The Modified duration of the portfolio is around 2.72 years for the debt portion
    • We intend to have a portfolio with a larger allocation towards gilts as we move ahead.
What should an investor do?

For investments in debt oriented products:

  • We believe that the investors with a shorter investment horizon may continue investments in ultra-short term and low duration funds
  • For a medium to long term investment horizon and with a suitable risk appetite, an allocation to Short Term Fund and Dynamic Bond Fund merits attention.

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • Investors looking to invest for a medium to long period, can consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in mid cap fund as well.
Scheme Name Product Suitability Riskometer
Mahindra Manulife Overnight Fund
An open ended debt scheme investing in overnight securities
This Product is suitable for investors who are seeking*:
  • To generate reasonable returns with high levels of safety and convenience of liquidity over short term
  • To invest in debt and money market instruments having maturity of upto 1 business day
Mahindra Manulife Arbitrage Yojana
An open ended scheme investing in arbitrage opportunities
This Product is suitable for investors who are seeking*:
  • Income over short term
  • Income through arbitrage opportunities between cash and derivative market and arbitrage opportunities within the derivative segment.
Mahindra Manulife Liquid Fund
An Open Ended Liquid scheme
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
Mahindra Manulife Short Term Fund
An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years (please refer to page no. 35 of SID)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
Mahindra Manulife Low Duration Fund
An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months (Please refer page 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in debt and money market instruments
Mahindra Manulife Ultra Short Term Fund
An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months (please refer to page no. 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
Mahindra Manulife Dynamic Bond Yojana
An open ended dynamic debt scheme investing across duration 
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation through active management of portfolio
  • Investments in debt & money market instruments across duration.
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
An open ended scheme investing in equity, arbitrage and debt
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments
Mahindra Manulife ELSS Kar Bachat Yojana
An open ended equity linked saving scheme with a statutory lock in of 3 years and tax benefit
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities
Mahindra Manulife Focused Equity Yojana
An open ended equity scheme investing in maximum 30 stocks across market caps (i.e Multi Cap)
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation.
Mahindra Manulife Top 250 Nivesh Yojana
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and Mid cap companies.
Mahindra Manulife Multi Cap Badhat Yojana
Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives.
Mahindra Manulife Mid Cap Unnati Yojana
Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies
Mahindra Manulife Large Cap Pragati Yojana
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Mahindra Manulife Hybrid Equity Nivesh Yojana
An open ended hybrid scheme investing predominantly in equity and equity related instruments
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income;
  • Investment in equity and equity related instruments and debt and money market instruments
Mahindra Manulife Rural Bharat and Consumption Yojana
An open ended scheme following Rural India theme
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/ or expected to benefit from the growth in rural India.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno.01018

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

MF banner